Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to

Condition:   Prevention of Swine InfluenzaIntervention:   Biological: Swine InfluenzaSponsor:   Novartis VaccinesCompleted - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials